ScholarLens Back to search
2013•Advances in Cardiovascular DiseasesRequires access

Prevention of In-stent Restenosis New Strategy

Shu-sen Yang

Open publisher page 0 citations

Abstract

Stent as a drug controlled release platform,is an effective means of reducing neointimal hyperplasia by controling drug release and convey.Drug-eluting stent(DES) restenosis may still occur especially when stents are used in complex anatomical and clinical scenarios which indicated that still need to be improved.This article summarizes the relationship in the drug-eluting stent parameters and discuss these parameters play what role in anti-restenosis process and order to provide a reference for reducing restenosis.

About this research paper

What this paper is about

Stent as a drug controlled release platform,is an effective means of reducing neointimal hyperplasia by controling drug release and convey.Drug-eluting stent(DES) restenosis may still occur especially when stents are used in complex anatomical and clinical scenarios which indicated that still need to be improved.This article summarizes the relationship in the drug-eluting stent parameters and discuss these parameters play what role in anti-restenosis process and order to provide a reference for reducing restenosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Stent as a drug controlled release platform,is an effective means of reducing neointimal hyperplasia by controling drug release and convey.Drug-eluting stent(DES) restenosis may still occur especially when stents are used in complex anatomical and clinical scenarios which indicated that still need to be improved.This article summarizes the relationship in the drug-eluting stent parameters and discuss these parameters play what role in anti-restenosis process and order to provide a reference for reducing restenosis.

Key concepts: Restenosis, Medicine, Coronary restenosis, Stent, Drug, Neointimal hyperplasia, Cardiology, Drug-eluting stent

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prevention of In-stent Restenosis New Strategy — Research Paper | ScholarLens